DANDEKAR ATUL (CSBO) sold 41.7% of their position (7.50K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $332.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 2/2/2026ACC: 0002050167-26-000003
Officer· CSBO
Since Feb 2026
-7.50K
Net shares
Net seller
$332.0K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
7.50K acquired · 15K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+7.50K
Price / share
$10.42
Trade value
$78.15K
% of position
71.4%
1/29/2026
10.50K→18K
Common Stock
Direct
Shares
−1.20K
Price / share
$43.18
Trade value
$51.82K
% of position
6.7%
1/29/2026
18K→16.80K
Common Stock
Direct
Shares
−3.50K
Price / share
$44.04
Trade value
$154.15K
% of position
20.8%
1/29/2026
16.80K→13.30K
Common Stock
Direct
Shares
−2.80K
Price / share
$45.01
Trade value
$126.02K
% of position
21.0%
1/29/2026
13.30K→10.50K
Total
Net shares
+0.00
Net value
-$253.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2026 | M · Option Exercise | +7.50K | $10.42 | $78.15K | 71.4% | 10.50K | 18K |
| Common Stock Direct | 1/29/2026 | S · Sale | −1.20K | $43.18 | $51.82K | 6.7% | 18K | 16.80K |
| Common Stock Direct | 1/29/2026 | S · Sale | −3.50K | $44.04 | $154.15K | 20.8% | 16.80K | 13.30K |
| Common Stock Direct | 1/29/2026 | S · Sale | −2.80K | $45.01 | $126.02K | 21.0% | 13.30K | 10.50K |
| Total | +0.00 | -$253.84K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.50K shares
Shares
−7.50K
Strike price
10.42
Held after
66.64K
Exercisable
—
1/29/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock7.50K shares | 1/29/2026 | M · Option Exercise | −7.50K | 10.42 | — | 66.64K |